mifepristone has been researched along with naloxone in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 12 (41.38) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| De Kloet, ER; Eijgelshoven, MH; Van den Berg, DT; Van Giersbergen, PL | 1 |
| Armario, A; Garvey, JS; Giralt, M; Hidalgo, J | 1 |
| Calignano, A; Capasso, A; Persico, P; Sorrentino, L | 1 |
| Bopp, BL; Fossum, G; Lobo, RA; Mishell, DR; Shoupe, D; Spitz, IM | 1 |
| Chatterton, RT; Fox, SR; Smith, MS | 1 |
| Deis, RP; Soaje, M | 2 |
| Capasso, A; Di Giannuario, A; Loizzo, A; Pieretti, S; Sagratella, S; Sorrentino, L | 1 |
| Benowitz, NL; Heller, PH; Levine, JD; Miao, FJ | 1 |
| Carón, RW; Deis, RP; Salicioni, AM | 2 |
| Almeida, OF; Deicke, J; Fischer, D; Gärtner, P; Hassan, AH; Hellbach, S | 1 |
| Levine, JD; Miao, FJ | 1 |
| Antonijevic, IA; Bicknell, RJ; Douglas, AJ; Leng, G; Russell, JA | 1 |
| de Di Nasso, EG; Deis, RP; Soaje, M | 1 |
| Fournier, NM; Galic, MA; Martin, LJ | 1 |
| Lam, S; McNally, GP | 1 |
| Bregonzio, C; Deis, RP; Penissi, A; Soaje, M; Valdez, S | 1 |
| Deis, R; Ezquer, M; Gabutti, CV; Maldonado, C; Soaje, M | 1 |
| Cao, J; Dong, Z; Han, H; Xu, L | 1 |
| Hajhashemi, V; Minaiyan, M; Movahedian, A; Sadeghi, H; Talebi, A | 1 |
| Hidalgo, JM; Laorden, ML; Milanés, MV; Navarro-Zaragoza, J | 1 |
| Bregonzio, C; de Di Nasso, EG; Gamboa, DF; Pennacchio, GE; Soaje, M; Valdez, SR | 1 |
| Laorden, ML; Milanés, MV; Navarro-Zaragoza, J | 1 |
| Jahn, GA; Pennacchio, GE; Soaje, M; Villegas-Gabutti, C | 1 |
| Jahn, GA; Pennacchio, GE; Soaje, M; Villegas-Gabutti, CM; Vivas, L | 1 |
1 review(s) available for mifepristone and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
28 other study(ies) available for mifepristone and naloxone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Activation of glucocorticoid receptors and the effect of naloxone during hemorrhagic hypotension.
Topics: Adrenalectomy; Animals; Corticosterone; Drug Interactions; Hemodynamics; Male; Mifepristone; Naloxone; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Shock, Hemorrhagic | 1991 |
Effect of morphine administration on rat liver metallothionein and zinc metabolism.
Topics: Animals; Immobilization; Injections, Subcutaneous; Liver; Male; Metallothionein; Mifepristone; Morphine; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Zinc | 1991 |
The action of dexamethasone on electrically-induced contractions of guinea-pig isolated ileum.
Topics: Animals; Cycloheximide; Dactinomycin; Dexamethasone; Electric Stimulation; Guinea Pigs; Ileum; In Vitro Techniques; Male; Mifepristone; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Receptors, Glucocorticoid | 1991 |
Antiprogestin treatment decreases midluteal luteinizing hormone pulse amplitude and primarily exerts a pituitary inhibition.
Topics: Adult; Analysis of Variance; Depression, Chemical; Female; Humans; Hydrocortisone; Luteal Phase; Luteinizing Hormone; Mifepristone; Naloxone; Pituitary Gland; Progesterone | 1990 |
Role of proestrous progesterone secretion in suppressing basal pulsatile LH secretion during estrus of the estrous cycle.
Topics: Animals; Estrus; Female; Immunization, Passive; Luteinizing Hormone; Mifepristone; Naloxone; Pentobarbital; Periodicity; Proestrus; Progesterone; Rats; Rats, Inbred Strains | 1989 |
A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat.
Topics: Animals; Bromocriptine; Endorphins; Female; Gestational Age; Mifepristone; Naloxone; Oxymorphone; Pregnancy; Pregnancy, Animal; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar | 1994 |
Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Cycloheximide; Dexamethasone; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Guinea Pigs; In Vitro Techniques; Male; Mifepristone; Muscle Contraction; Naloxone; Opioid-Related Disorders; Pyrrolidines; Rabbits; Substance Withdrawal Syndrome | 1996 |
Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat.
Topics: Adrenal Glands; Animals; Bradykinin; Capillary Permeability; Male; Mecamylamine; Mifepristone; Naloxone; Nicotine; Platelet Activating Factor; Propanolamines; Rats; Rats, Sprague-Dawley | 1997 |
Participation of both adrenergic and opioidergic systems in the negative feedback of adrenal progesterone on LH secretion.
Topics: Adrenal Glands; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Estradiol; Feedback; Female; Hormone Antagonists; Idazoxan; Luteinizing Hormone; Metoprolol; Mifepristone; Naloxone; Ovariectomy; Prazosin; Progesterone; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Opioid | 1997 |
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Gestational Age; Hormone Antagonists; Mifepristone; Naloxone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 1997 |
Regulation of prolactin secretion by adrenal steroids in oestrogen-treated ovariectomized rats: participation of endogenous opioid peptides.
Topics: Animals; Anti-Inflammatory Agents; Estradiol; Female; Hormone Antagonists; Hydrocortisone; Mifepristone; Naloxone; Opioid Peptides; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Wistar | 1997 |
Inherent glucocorticoid response potential of isolated hypothalamic neuroendocrine neurons.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine Vasopressin; beta-Endorphin; Calcium; Cells, Cultured; Coculture Techniques; Corticotropin-Releasing Hormone; Culture Media, Serum-Free; Dexamethasone; Glucocorticoids; Kinetics; Male; Mifepristone; Morphine; Naloxone; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Sodium; Tetrodotoxin; Verapamil; Veratridine | 1998 |
Neural and endocrine mechanisms mediating noxious stimulus-induced inhibition of bradykinin plasma extravasation in the rat.
Topics: Adrenal Glands; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bradykinin; Capsaicin; Electric Stimulation; Endocrine Glands; Hypophysectomy; Knee Joint; Male; Mifepristone; Naloxone; Narcotic Antagonists; Nervous System Physiological Phenomena; Neurons, Afferent; Pain; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sympathetic Nervous System; Synovial Fluid | 1999 |
Effect of progesterone on the activation of neurones of the supraoptic nucleus during parturition.
Topics: Analysis of Variance; Animals; Depression, Chemical; Female; Gene Expression; Genes, fos; Hormone Antagonists; Immunohistochemistry; Labor, Obstetric; Mifepristone; Naloxone; Narcotic Antagonists; Neurons; Oxytocin; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Supraoptic Nucleus | 2000 |
Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: role of ovarian steroids.
Topics: Animals; Estrogen Antagonists; Female; Hormone Antagonists; Lactation; Maternal Behavior; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 2002 |
Alpha2-adrenergic inhibition prevents the accompanied anticonvulsant effect of swim stress on behavioral convulsions induced by lithium and pilocarpine.
Topics: Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Lithium; Male; Mifepristone; Naloxone; Pilocarpine; Rats; Rats, Wistar; Seizures; Stress, Physiological; Swimming; Yohimbine | 2004 |
Altered vulnerability to acute opiate withdrawal following stress: roles of N-methyl-D-aspartate and glucocorticoid receptors.
Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hormone Antagonists; Male; Mifepristone; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, N-Methyl-D-Aspartate; Restraint, Physical; Stress, Physiological; Time Factors | 2005 |
Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Enzyme Inhibitors; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Hydrazines; Hypothalamus; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2006 |
Pituitary changes involved in prolactin secretion induced by mifepristone and naloxone during late pregnancy.
Topics: Animals; Female; Lactotrophs; Mifepristone; Naloxone; Pituitary Gland; Pregnancy; Prolactin; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 2009 |
Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Topics: Analgesics, Opioid; Animals; CA1 Region, Hippocampal; Excitatory Postsynaptic Potentials; Male; Mifepristone; Morphine; Naloxone; Narcotic Antagonists; Neuronal Plasticity; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, N-Methyl-D-Aspartate; Stress, Psychological; Substance Withdrawal Syndrome; Synapses; Synaptic Transmission; Time Factors | 2010 |
Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Carrageenan; Edema; Hormone Antagonists; Indomethacin; Injections, Spinal; Male; Maprotiline; Mifepristone; Naloxone; Narcotic Antagonists; Prazosin; Propranolol; Rats; Rats, Wistar; Yohimbine | 2010 |
Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.
Topics: Animals; Hormone Antagonists; Male; Mifepristone; Morphine Dependence; Naloxone; Narcotic Antagonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Solitary Nucleus; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase | 2012 |
Opioid modulation of prolactin secretion induced by stress during late pregnancy. Role of ovarian steroids.
Topics: Analgesics, Opioid; Animals; Estradiol; Female; Mifepristone; Naloxone; Naltrexone; Narcotic Antagonists; Ovary; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Steroids; Tamoxifen | 2014 |
Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
Topics: Analgesics, Opioid; Animals; Cyclic AMP Response Element-Binding Protein; Dopamine; Hormone Antagonists; Male; MAP Kinase Signaling System; Mifepristone; Mineralocorticoid Receptor Antagonists; Morphine; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase | 2017 |
Role of Estradiol in the Regulation of Prolactin Secretion During Late Pregnancy.
Topics: Animals; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Hypothalamus, Middle; Mifepristone; Naloxone; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, Progesterone; Receptors, Prolactin; Tyrosine 3-Monooxygenase | 2016 |
Role of Oxytocin in Prolactin Secretion during Late Pregnancy.
Topics: Animals; Bodily Secretions; Female; Hormone Antagonists; Lactotrophs; Mifepristone; Naloxone; Narcotic Antagonists; Oxytocin; Pregnancy; Prolactin; Rats; Rats, Wistar | 2018 |